Drug fluency: A potential marker for cocaine use disorders

被引:18
|
作者
Goldstein, R. Z.
Woicik, P. A.
Lukasik, T.
Maloney, T.
Volkow, N. D.
机构
[1] Brookhaven Natl Lab, Med Dept, Upton, NY 11973 USA
[2] Natl Inst Drug Abuse, Bethesda, MD 20892 USA
关键词
semantic memory; cocaine; drug addiction; salience; cue-reactivity; craving; prefrontal cortex;
D O I
10.1016/j.drugalcdep.2006.12.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The goal of the current study was to tailor semantic fluency to increase its sensitivity and ecological validity in the study of drug use disorders. On a newly modified "drug" fluency task, individuals with cocaine use disorders who tested positive for cocaine at study day named more drug-related words than control subjects. The number of words provided on the classical semantic fluency task (animals and fruits/vegetables) did not differ between the groups. While the individuals with cocaine use disorders who tested negative for cocaine at study day did not differ from the control subjects in total words named on this task, a qualitative analysis indicated that both cocaine subgroups provided significantly more words pertaining to the experience of using drugs (paraphernalia, administration) than the matched control subjects. These results demonstrate that compared to classical neurocognitive assessment tools, newly tailored measures may be more sensitive to cocaine use disorders, psychopathologies that are often characterized by mild neuropsychological deficits but a well-circumscribed attentional bias to drug-related cues. Future studies are needed to probe the exact cognitive processes and neural circuitry underlying performance on this cue-sensitive 1-min measure. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 50 条
  • [1] The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders
    Mahoney, James J., III
    De La Garza, Richard, II
    Jackson, Brian J.
    Verrico, Christopher D.
    Ho, Allyson
    Iqbal, Tabish
    Newton, Thomas F.
    PSYCHIATRY RESEARCH, 2014, 219 (02) : 367 - 371
  • [2] Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
    Raul Garcia
    Tien Le
    Samantha N. Scott
    Delaram Charmchi
    Jamie M.L. Sprout
    Nathan S. Pentkowski
    Janet L. Neisewander
    Translational Psychiatry, 10
  • [3] Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
    Garcia, Raul
    Le, Tien
    Scott, Samantha N.
    Charmchi, Delaram
    Sprout, Jamie M. L.
    Pentkowski, Nathan S.
    Neisewander, Janet L.
    TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)
  • [4] Changes in the Association of Drug Use with Depressive Disorders in Recent Decades: The Case of Cocaine
    Bohnert, Amy S. B.
    Miech, Richard A.
    SUBSTANCE USE & MISUSE, 2010, 45 (10) : 1452 - 1462
  • [5] A Tale of Two Atypical DAT Inhibitors and Their Potential to Treat Cocaine Use Disorders
    Newman, Amy
    Cao, Jianjing
    Bi, Guohua
    Tanda, Gianluigi
    Xi, Zheng-Xiong
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S285 - S286
  • [6] Drug use patterns and drug-related disorders of cocaine users in a sample of the general population in Germany
    Kraus, Ludwig
    Augustin, Rita
    Kunz-Ebrecht, Sabine
    Orth, Boris
    EUROPEAN ADDICTION RESEARCH, 2007, 13 (02) : 116 - 125
  • [7] Is cocaethylene a marker of ethanol use in cocaine users?
    Kapur, Bhushan
    CLINICAL BIOCHEMISTRY, 2014, 47 (12) : 1151 - 1151
  • [8] Cocaine use disorders and suicidal ideation
    Garlow, SJ
    Purselle, D
    D'Orio, B
    DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (01) : 101 - 104
  • [9] NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH COCAINE USE
    MENDOZA, R
    MILLER, BL
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1992, 43 (07): : 677 - &
  • [10] Comorbidities in patients with cocaine use disorders
    Jimenez-Silvestre, Karina
    Rodriguez-Kuri, Solveig E.
    Fernandez-Caceres, Carmen
    Marin-Navarrete, Rodrigo
    JOURNAL OF SUBSTANCE USE, 2024,